These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 1477444)

  • 21. [Anti-angina therapy of coronary heart disease. Mono- or combination treatment].
    Kurz T; Rauch B; Kübler W
    Z Kardiol; 1991 May; 80(5):305-16. PubMed ID: 1678565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on calcium-channel blocking agents.
    Talbert RL; Bussey HI
    Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical pharmacology of calcium entry blockers.
    Bianchi CP
    Cardiovasc Clin; 1983; 14(1):123-8. PubMed ID: 6311420
    [No Abstract]   [Full Text] [Related]  

  • 24. [Combination of anti-angina drugs].
    Silber S
    Z Kardiol; 1989; 78 Suppl 2():160-74; discussion 188-9. PubMed ID: 2573981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical uses of calcium antagonists.
    Hope RR; Lazzara R
    Adv Intern Med; 1982; 27():435-52. PubMed ID: 6462036
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pharmacology and clinical use of a fixed combination of nifedipine and slow release atenolol (Niften) in the treatment of arterial hypertension and angina pectoris].
    Verdecchia P
    Minerva Cardioangiol; 1993 Sep; 41(9):349-63. PubMed ID: 7903118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium-channel blockers in vasospastic angina--a review.
    Ambrosio G
    Postgrad Med J; 1983; 59 Suppl 3():26-9. PubMed ID: 6359108
    [No Abstract]   [Full Text] [Related]  

  • 28. Sustained improvement of pulmonary haemodynamics with low-dose of nifedipine in primary pulmonary hypertension.
    Shimabukuro M; Chibana T; Yoshida H; Nagamine F; Takasu N
    Eur Heart J; 1996 Dec; 17(12):1911-2. PubMed ID: 8960436
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical benefits versus shortcomings of diltiazem once-daily in the chronotherapy of cardiovascular diseases.
    Ezeugo U; Glasser SP
    Expert Opin Pharmacother; 2009 Feb; 10(3):485-91. PubMed ID: 19191683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nifedipine in acute coronary syndromes: Furberg's refrain revisited.
    Rafflenbeul W
    Eur Heart J; 1996 Aug; 17(8):1147-52. PubMed ID: 8869854
    [No Abstract]   [Full Text] [Related]  

  • 31. Calcium-channel blockers used in combination.
    Shaheen BE; Alaniz C
    Ann Pharmacother; 1992 Nov; 26(11):1387-8. PubMed ID: 1477444
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of angina pectoris with calcium antagonists].
    Hopf R; Becker HJ; Kober G; Dowinsky S; Kaltenbach M
    Herz; 1982 Aug; 7(4):221-34. PubMed ID: 6751971
    [No Abstract]   [Full Text] [Related]  

  • 33. [The role of calcium antagonists in the treatment of classical angina pectoris].
    Manger Cats V; Lie KI
    Ned Tijdschr Geneeskd; 1983 May; 127(21):918-23. PubMed ID: 6346115
    [No Abstract]   [Full Text] [Related]  

  • 34. High-dose monotherapy and combination therapy with calcium channel blockers for angina. A comprehensive review of the literature.
    Temkin LP
    Am J Med; 1989 Jan; 86(1A):23-7. PubMed ID: 2563636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of calcium channel blocking agents in angina pectoris.
    Breland BD; Boland MJ
    J Miss State Med Assoc; 1984 Mar; 25(3):57-62. PubMed ID: 6371246
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.